Having trouble viewing? View as Webpage

Dear Tamira,

Through your support, MPNRF has funded nearly 25 years of foundational preclinical research. Together, we have helped pave the way toward a better understanding of the causes and treatment of essential thrombocythemia, polycythemia vera, and myelofibrosis. We can’t thank you enough for your part in advancing the research to where it is today.

Now, your continued help is crucial to forge tomorrow’s cures. We are counting on your support. Your gift today supports future research breakthroughs.

From earlier diagnosis and treatments, to preventing disease progression and reversing the drivers of these rare blood cancers, your investments in MPN research change the prognosis for people living with MPNs.

Our MPN Challenge and Thrive research awards supported uniquely collaborative projects across institutions and around the globe, including capitalizing on what is being learned about other blood cancers.  

This type of collective knowledge will accelerate our progress, helping us move from symptom management to longer survival with a better quality of life.